Debiopharm Group, a Swiss-based global biopharmaceutical company, today announced that the US Food and Drug Administration granted Fast Track designation to its anti-infectious agent Debio 1450, a highly potent antibiotic specifically active against all Staphylococcus species.
from The Medical News http://ift.tt/1xISo76
from The Medical News http://ift.tt/1xISo76
No comments:
Post a Comment